Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-25-003913
Filing Date
2025-06-16
Accepted
2025-06-16 16:19:43
Documents
2
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5898
2 EXHIBIT 24 exh_24.htm EX-24 7811
  Complete submission text file 0001171843-25-003913.txt   15154
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address
HEGGIE THERESA (Reporting) CIK: 0001760020 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 251050355